151 related articles for article (PubMed ID: 18787214)
1. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.
Sozzi G; Roz L; Conte D; Mariani L; Andriani F; Lo Vullo S; Verri C; Pastorino U
Am J Respir Crit Care Med; 2009 Jan; 179(1):69-74. PubMed ID: 18787214
[TBL] [Abstract][Full Text] [Related]
2. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti MA; Tavecchio L
Cancer Res; 2001 Jun; 61(12):4675-8. PubMed ID: 11406535
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
6. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
van der Drift MA; Hol BE; Klaassen CH; Prinsen CF; van Aarssen YA; Donders R; van der Stappen JW; Dekhuijzen PN; van der Heijden HF; Thunnissen FB
Lung Cancer; 2010 May; 68(2):283-7. PubMed ID: 19632736
[TBL] [Abstract][Full Text] [Related]
7. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
[TBL] [Abstract][Full Text] [Related]
9. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
10. Screening for lung cancer with digital chest radiography: sensitivity and number of secondary work-up CT examinations.
de Hoop B; Schaefer-Prokop C; Gietema HA; de Jong PA; van Ginneken B; van Klaveren RJ; Prokop M
Radiology; 2010 May; 255(2):629-37. PubMed ID: 20413773
[TBL] [Abstract][Full Text] [Related]
11. Quantification of serum MET in non-small-cell lung cancer and its clinical significance.
Li D; Li F; Wu Y; Zhou D; Chen H
Clin Biochem; 2015 Feb; 48(3):110-4. PubMed ID: 25489726
[TBL] [Abstract][Full Text] [Related]
12. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of a prototype dual-energy chest imaging system ROC analysis.
Kashani H; Varon CA; Paul NS; Gang GJ; Van Metter R; Yorkston J; Siewerdsen JH
Acad Radiol; 2010 Mar; 17(3):298-308. PubMed ID: 20042351
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.
Infante M; Lutman FR; Cavuto S; Brambilla G; Chiesa G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Alloisio M; Incarbone M; Testori A; Destro A; Cappuzzo F; Roncalli M; Santoro A; Ravasi G;
Lung Cancer; 2008 Mar; 59(3):355-63. PubMed ID: 17936405
[TBL] [Abstract][Full Text] [Related]
18. Improving lung cancer prognosis assessment by incorporating synthetic minority oversampling technique and score fusion method.
Yan S; Qian W; Guan Y; Zheng B
Med Phys; 2016 Jun; 43(6):2694-2703. PubMed ID: 27277016
[TBL] [Abstract][Full Text] [Related]
19. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
20. Effect of temporal subtraction images on radiologists' detection of lung cancer on CT: results of the observer performance study with use of film computed tomography images.
Abe H; Ishida T; Shiraishi J; Li F; Katsuragawa S; Sone S; Macmahon H; Doi K
Acad Radiol; 2004 Dec; 11(12):1337-43. PubMed ID: 15596371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
